Scientific articles and conferences

Scientific articles and conferences

Articles since 2007

Articles in cooperation since 2007

Conferences since 2007

  • Tęcza P, Kędzierska M, Kurczewska M, Potemski P: Czy lokalizacja czerniaka BRAF (+) w skórze gruczołu piersiowego wpływa na rokowanie i postępowanie terapeutyczne? XXIII Kongres Polskiego Towarzystwa Onkologii Klinicznej, Kraków, Polska, 27–29 August 2020
  • Hartman ML, Gajos-Michniewicz A, Talaj J, Mielczarek-Lewandowska A, Kluszczynska K, Tecza P, Czyz M: S63845, a selective inhibitor of MCL-1, cooperates with encorafenib in induction of apoptosis in BRAFV600E melanoma cells. 10th World Congress of Melanoma in conjunction with 17th EADO Congress, Interactive virtual meeting, 15-17 April 2021
  • Sztiller-Sikorska M, Hartman ML, Gajos-Michniewicz A, Tecza P, Czyz M: Mapping the hallmarks of melanoma resistance to vemurafenib or trametinib revealed genetic and non-genetic patient- and drug-specific alterations and a high phenotypic plasticity. 10th World Congress of Melanoma in conjunction with 17th EADO Congress, Interactive virtual meeting, 15-17 April 2021
  • Hartman ML: “Modulation of the activity of BCL-2 proteins as a potential therapeutic
    target in drug-naive and targeted therapy-resistant melanoma.     Webinar „"Molecular basis of cancer pathophysiology and anticancer therapies”, Lodz Division of the Polish Biochemical Society, 25 April 2024
  • Hartman ML, Gajos-Michniewicz A, Talaj J.A., Mielczarek-Lewandowska A, Czyz M Encorafenib alters melanoma cell proximity to the apoptotic threshold – implications for complementary therapeutic strategy using selective BH3 mimetics. XXIV Gliwice Scientific Meetings, Gliwice, Poland, 20-21 November 2020
  • Czyz M, Osrodek M, Gajos-Michniewicz A, Sztiller-Sikorska M Oxygen concentration contributes to phenotypic heterogeneity of melanoma during adaptive response to targeted therapeutics. Nature Conference on Cellular Metabolism; Xiamen, China, 8-11 April 2019
  • Osrodek M, Hartman ML, Czyz M Response of melanoma cells to vemurafenib and trametinib at the level of metabolic phenotype. Nature Conference on Cellular Metabolism; Xiamen, China, 8-11 April 2019
  • Rogut ME, Hartman ML, Mielczarek-Lewandowska A, Sztiller-Sikorska M, Gajos-Michniewicz A, Czyz M The effect of 17-aminogeldanamycin on NF-κB activity in patient-derived melanoma cell lines. 11th International Conference of Contemporary Oncology, Poznań, Poland 13-15 March 2019
  • Mielczarek-Lewandowska A, Hartman ML, Sztiller-Sikorska M, Osrodek M, Gajos-Michniewicz A, Czyz M 17-aminogeldanamycin inhibits cytoprotective UPR pathways and cooperates with inhibitors of the MAPK signaling cascade in apoptosis induction. Melanoma: from biology to target; Houston, USA 15-18 January 2019
  • Rogut M, Zietara M, Hartman ML, Czyz M, Wilczynski J, Szubert M Is it possible to diagnose endometriosis at the level of endometrium? Gynecological Endocrinology: The 18th World Congress; Florence, Italy, 7-10 March 2018
    Czyż M (Speaker) Feverfew and parthenolide – phytochemical, pharmacological and clinical evidence. A Scientific Workshop; Vienna, Austria, 16 November 2017
  • Hartman ML, Sztiller-Sikorska M, Ośrodek M, Zaleśna I, Mielczarek A, Czyż M V600EBRAF melanoma cell response to vemurafenib and trametinib is not affected by exogenous growth factors bFGF, EGF and HGF in vitro. 9th World Congress of Melanoma; Brisbane, Australia; 18-21 October 2017
  • Ośrodek M, Hartman ML, Różański M,  Sztiller-Sikorska M, Niewinna K, Czyż M Composition or lack of exogenous growth factors do not influence viability and phenotype of drug- naïve V600EBRAF melanoma cells but it might be crucial for drug-resistant cells. 9th World Congress of Melanoma; Brisbane, Australia; 18-21 October 2017
  • Hartman M, Gajos-Michniewicz A, Talar B, Czyż M MCL-1 protects patient-derived melanoma cells from death during rapid changes in microenvironment. EACR Conference Series: A Matter of Life or Death; Mechanisms and Relevance of Cell Death for Cancer Biology and Treatment  2016; Amsterdam, Netherlands; 28-30 January 2016
  • Zaleśna I, Różański M, Sztiller-Sikorska M, Hartman M, Czyż M: Melanoma cell plasticity in response to diverse growth factors. EMBL Symposium: Tumor Microenvironment and Signalling 2016; Heidelberg, Germany; 03-06 April 2016
  • Ośrodek M, Hartman M, Różański M, Zaleśna I, Talar B, Niewinna K, Sztiller-Sikorska M, Nowicki J, Nejc D, Czyż M: Response of patient-derived melanoma cells to different growth factors. 2nd EACR Conference: Goodbye Flat Biology; Models, Mechanisms and Microenvironment 2016; Berlin, Germany; 02-05 October 2016
  • Hartman ML, Stiller-Sikorska M, Mielczarek A, Talar B, Nejc D, Czyż M: Natural compound parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-Mhigh melanoma cell populations. XXth Gliwice Scientific Meetings 2016; Gliwice, Poland; 18-19 November 2016
  • Talar B, Gajos-Michniewicz A, Czyż M: Modulation of canonical WNT pathway In patent-derived melanoma cell lines by natura compounds. Conference for Young Scientists 2015; Kijów, Ukraina; 21-25 September 2015
  • Gajos-Michniewicz A, Talar B, Hartman ML, Czyż M: Microenvironment-driven alterations of invasive potential of patent-derived melanoma cells. Conference for Young Scientists 2015; Kijów, Ukraina; 21-25 September 2015
  • Hartman ML, Sztiller-Sikorska M, Talar B, Gajos-Michniewicz A, Czyż M: Immediate and long-term molecular response of melanoma cells to changes in microenvironment. XVIIIth Gliwice Scientific Meetings 2014; Gliwice, 21-22 November 2014
  • Czyż M, Majchrzak K, Koprowska K, Hartman M, Sztiller-Sikorska M: Short- and long-term effects of natural compounds on melanoma cells derived from surgical specimens. Cell Death Signaling In Cancer and the Immune System; Guaruja, Sao Paulo, Brazil; 28 October – 2 November 2014
  • Hartman M, Talar B, Gajos-Michniewicz A, Czyż M: Diverse pro-survival responses of heterogeneous melanoma cell lines to changes in microenvironment. Cell Death Signaling In Cancer and the Immune System; Guaruja, Sao Paulo, Brazil; 28 October – 2 November 2014
  • Toma M, Gajos-Michniewicz A, Majchrzak K, Wieteska Ł, Szemraj J, Czyż M, Skorski T, Śliwiński T: Personalized synthetic lethality induced by targeting RAD52 and PARP1 in melanomas. The Ninth International Conference of Anticancer Research; Sithonia, Greece; 6-10 October 2014
  • Woźniak M, Gajos-Michniewicz A, Sztiller-Sikorska M, Pęczek Ł, Duechler M, Czyż M: MiRNAs from exosomes released by melanoma cells grown in 3-dimensional manner. Tissue Models and Drug Screening Conference; Berlin; 6-7 May 2014
  • Sztiller-Sikorska M, Majchrzak K, Hartman M, Czyż M: Short- and long-term effects of natural compounds on melanoma cells grown in anchorage-independent manner. Tissue Models and Drug Screening Conference; Berlin; 6-7 May 2014
  • Czyż M (Invited Speaker): Heterogeneity of melanospheres: therapeutic implications. XVII Gliwice Scientific Meetings; Gliwice; 15-16 November 2013
  • Hartman MŁ, Sztiller-Sikorska M, Talar B, Chouaib S, Czyż M: Transcriptome profiles of melanospheres and monolayers derived from nodular melanoma specimens. XVII Gliwice Scientific Meetings; Gliwice; 15-16 November 2013
  • Talar B, Sztiller-Sikorska M, Gajos-Michniewicz A,  Koprowska K, Czyż M: Phenotypic heterogeneity and plasticity of cells in melanospheres derived from nodular melanoma specimens. XVII Gliwice Scientific Meetings; Gliwice; 15-16 November 2013
  • Woźniak M, Sztiller-Sikorska M, Czyż M: Differential expression of microRNA in diverse phenotypes of melanoma cells. XVII Gliwice Scientific Meetings; Gliwice; 15-16 November 2013
  • Czyż M, Hartman M, Talar B, Gajos-Michniewicz A, Zaleśna I, Sztiller-Sikorska M, Zaeem N, Salem C: Melanoma morphologic, molecular and functional diversity in vitro. Nature – CNIO Cancer Symposium on Frontiers in Tumour Heterogeneity and Plasticity; Madrid, Spain; 27-30 October 2013
  • Czyż M (Invited Expert): Heterogeneity and plasticity of melanospheres: implications for development of therapeutic strategies. European Cooperation in Science and Technology, COST Action CM1106 2nd Working Group Meeting. Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells; Warsaw, 19-20 September 2013
  • Pastuszko A, Kupcewicz B, Czyż M, Małecka M, Budzisz E: Cytotoxic activity of novel half-sandwich organoruthenium(II) complexes. XII International Symposium on Inorganic Biochemistry; Wroclaw; 28 August–1 September 2013
  • Duchler M, Pęczek Ł, Żuk K, Zaleśna I, Pluta P, Jeziorski A, Czyż M: Analysis of the immunosuppressive microenvironment in tumor samples from breast cancer patients. 3rd International Cancer Immunotherapy & Immunomonitoring CITIM; Cracow; 22-25 April 2013
  • Czyż M, Koprowska K, Hartman M, Zaleśna I, Duechler M, Sztiller-Sikorska M: Microenvironment-dependent phenotypic heterogeneity of melanoma cells. Cell Symposia: Hallmarks of Cancer; San Francisco, USA; 29-31 October 2012
  • Szubert M, Kowalczyk-Amico K, Szuławska A, Duechler M, Czyż M, Suzin J: Angiogenesis and inflammatory response in endometriosis – the role of danazol treatment. 15th World Congress of Gynecological Endocrinology; Firenze, Italy; 7-10 March 2012
  • Szubert M, Duechler M, Szuławska A, Suzin J, Czyż M, Kowalczyk-Amico K: Biomarkers of angiogenesis and inflammatory response in peritoneal fluid of women with endometriosis. 5th World Congress of Gynecological Endocrinology; Firenze, Italia; 7-10 March 2012; Giornale Italiano Ostetricia Ginecologia 34: 321-322
  • Koprowska K, Jakubowska J, Sztiller-Sikorska M, Czyż M: Parthenolide enhances the anti-tumor efficacy of dacarbazine and temozolomide in melanoma cells with cancer stem cells properties. FEBS Advanced Lecture Course on Translational Cancer Research; Portugal; 27 September-4 October 2011
  • Czyż M (Invited Speaker): Reversible phenotypic heterogeneity among melanoma stem-like cells. The 5th Polish-French Conference on Cancer Biology and Therapy; Paris, France; 30 May-1 June 2011
  • Czyż M, Lesiak-Mieczkowska K, Szuławska-Mroczek A, Woźniak M, Jakubowska J: Targeting constitutive and inducible NF-κB pathway by parthenolide in primary and metastatic melanoma cells. Perspectives in Melanoma XIV; Amsterdam, Netherlands; 17-18 September 2010
  • Grażul M, Czyż M, Kufelnicki A, Woźniczka M, Budzisz E: Structure, protonation constants and cytotoxic effect of Co(II) and Pd(II) ion complexes with chromone ligand in melanoma cells. ISABC 10, 10th Internacional Symposium on Applied Bioinorganic Chemistry; Debrecen, Hungary; 25-28 September 2009
  • Koprowska K, Stasiak M, Czyż M: Cell cycle arrest or apoptosis are induced by parthenolide and cisplatin in melanoma cells in vitro. XLIV Annual Meeting of the Polish Biochemical Society; Lodz; 16-19 September 2009; Acta Biochemica Polonica 56: 50
  • Szuławska-Mroczek A, Woźniak M, Lesiak K, Czyż M: Effects of parthenolide and cisplatin on the NFκB-binding activity and expression of NFκB-dependent genes in melanoma cells. XLIV Annual Meeting of the Polish Biochemical Society; Lodz; 16-19 September 2009; Acta Biochemica Polonica 56: 51
  • Lesiak K, Zaleśna I, Nejc D, Czyż M: Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anti-cancer activity against human melanoma cells in vitro. XLIV Annual Meeting of the Polish Biochemical Society; Lodz; 16–19 September 2009; Acta Biochemica Polonica 56: 50
  • Jakubowska J, Sztiller-Sikorska M, Woźniak M, Stasiak M, Czyż M: Similarities between pharmacologically induced differentiation of K562 cells and normal erythropoiesis. XLIV Annual Meeting of the Polish Biochemical Society; Lodz; 16–19 September 2009; Acta Biochemica Polonica 56: 109
  • Sztiller-Sikorska M, Jakubowska J, Stasiak M, Czyż M: Caspase-3 is involved in chemically induced erythroid differentiation of K562 cell line. The Congress of Biochemistry and Cell Biology, 43rd Meeting of the Polish Biochemical Society and 10th Conference of the Polish Cell Biology Society; Olsztyn; 7-11 September 2008; Acta Biochemica Polonica 55: 76
  • Jakubowska J, Stasiak M, Sztiller-Sikorska M, Czyż M: Combined effects of STI571 and doxorubicin on growth, differentiation and apoptosis of K562 cell line. Apoptosis World 2008 – From mechanisms to applications; Luxembourg; 23-26 January 2008
  • Lesiak K, Duchler M, Czyż M: NF-κB inhibitors as novel approach against malignant melanoma. Apoptosis World 2008 – From mechanisms to applications; Luxembourg; 23-26 January 2008
  • Czyż M, Jakubowska [Arkusińska] J, Stasiak M, Szuławska A: Cooperative effects of STI571 (imatinib) and doxorubicin in promoting erythroid differentiation and apoptosis in CML cell line K562. 42nd Meeting of the Polish Biochemical Society; Szczecin; 18-21 September 2007; Acta Biochemica Polonica 54: 51-52
  • Jakubowska [Arkusińska] J, Stasiak M, Benarek A, Czyż M: STI571 (imatinib) and doxorubicin induction of erythroid differentiation and apoptosis in CML cell line K562 is accompanied by dissipation. 42nd Meeting of the Polish Biochemical Society; Szczecin; 18-21 September 2007; Acta Biochemica Polonica 54: 151
  • Lewandowska U, Płuciennik E, Czyż M, Hrabec E, Bednarek A: The role of WWOX normal and pathological cell metabolism. 42nd Meeting of the Polish Biochemical Society; Szczecin; 18-21 September 2007; Acta Biochemica Polonica 54: 53
  • Czyż M, Jakubowska J, Stasiak M, Szuławska A: Combinatorial effects of doxorubicin and STI571 on growth, differentiation and apoptosis of CML cell like K562. BIT's 5th Anniversary Congress of International Drug Discovery Science and Technology (IDDST); Shanghai, China; 28 May-5 June 2007
  • Duechler M, Stańczyk M, Czyż M, Stępnik M: Parthenolide and buthionine sulfoximine potentiate cytotoxicity of arsenic trioxide. BIT's 5th Anniversary Congress of International Drug Discovery Science and Technology (IDDST); Shanghai, China; 28 May-5 June 2007
Podziel się